BusinessCorrection: PetLife Pharmaceuticals Enters Negotiations with Key Founders of InnoVision Therapeutics to Discuss Expansion of its Core Product LineBy Nasdaq OMXDec 7, 2016, 1:50 PM UTC
BusinessPetLife Pharmaceuticals’ CEO Dr. Salvagno Provides White Paper on “Venenotherapy” While Preparing for FDA SubmissionBy Nasdaq OMXDec 6, 2016, 1:01 PM UTC
BusinessPetLife Pharmaceuticals’ CEO Dr. Salvagno Provides White Paper on “Venenotherapy” While Preparing for FDA SubmissionBy Nasdaq OMXDec 6, 2016, 1:01 PM UTC
